Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Martin, Egfjord"'
Autor:
Dimitrios Chanouzas, Julie Anne G. McGregor, Peter Nightingale, Alan D. Salama, Wladimir M. Szpirt, Neil Basu, Matthew David Morgan, Caroline J. Poulton, Juliana Bordignon Draibe, Elizabeth Krarup, Paula Dospinescu, Jessica Anne Dale, William Franklin Pendergraft, Keegan Lee, Martin Egfjord, Susan L. Hogan, Lorraine Harper
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background Intravenous pulse methylprednisolone (MP) is commonly included in the management of severe ANCA associated vasculitis (AAV) despite limited evidence of benefit. We aimed to evaluate outcomes in patients who had, or had not receive
Externí odkaz:
https://doaj.org/article/d35384d1bd6b44a894c8b93db0513a14
Autor:
Rasmus Dreier, Ulrik B. Andersen, Julie L. Forman, Majid Sheykhzade, Martin Egfjord, Jørgen L. Jeppesen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 9 (2021)
Background Increased potassium intake lowers blood pressure in patients with hypertension, but increased potassium intake also elevates plasma concentrations of the blood pressure‐raising hormone aldosterone. Besides its well‐described renal effe
Externí odkaz:
https://doaj.org/article/456b81994b4a4a3db5ff7eada00f2cf3
Autor:
Line Aas Mortensen, Helle C. Thiesson, Birgitte Tougaard, Martin Egfjord, Anne Sophie Lind Fischer, Claus Bistrup
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Calcineurin inhibitor induced nephrotoxicity contributes to late allograft failure in kidney transplant patients. Evidence points towards aldosterone to play a role in the development of fibrosis in multiple organs. Animal studies
Externí odkaz:
https://doaj.org/article/1c49dc1a881842fcbedbe2baf4a73c0e
Publikováno v:
Case Reports in Transplantation, Vol 2019 (2019)
Kaposi Sarcoma (KS) is driven by human herpes virus 8 causing vascular proliferation which is induced by loss of immune function most often due to HIV or immunosuppressants. KS occurs with increased incidence in kidney transplant recipients, but rare
Externí odkaz:
https://doaj.org/article/062e5ffa6166410889c7494da896146b
Autor:
Reimar Wernich Thomsen, Sia Kromann Nicolaisen, Pål Hasvold, Ricardo Garcia‐Sanchez, Lars Pedersen, Kasper Adelborg, Martin Egfjord, Kenneth Egstrup, Henrik Toft Sørensen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
BackgroundData on the true burden of hyperkalemia in patients with heart failure (HF) in a real‐world setting are limited. Methods and ResultsIncidence rates of hyperkalemia (first blood test with a potassium level >5.0 mmol/L) in primary or hospit
Externí odkaz:
https://doaj.org/article/4d552253fd4f40c39d6c0f0aed079b24
Autor:
Line Aas Mortensen, Bente Jespersen, Anne Sophie Lind Helligsø, Donata Cibulskyte-Ninkovic, Birgitte Godskesen Tougaard, Martin Egfjord, Lene Boesby, Niels Marcussen, Kirsten Madsen, Boye L Jensen, Inge Petersen, Claus Bistrup, Helle Charlotte Thiesson
Publikováno v:
Mortensen, L A, Jespersen, B, Helligsø, A S L, Cibulskyte-Ninkovic, D, Tougaard, B G, Egfjord, M, Boesby, L, Marcussen, N, Madsen, K, Jensen, B L, Petersen, I, Bistrup, C & Thiesson, H C 2022, ' FC 118: The Effect of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity—The Spiren Trial ', Nephrology Dialysis Transplantation, vol. 37, no. Supplement 3, gfac124.003 . https://doi.org/10.1093/ndt/gfac124.003
BACKGROUND AND AIMS Improving long-term allograft survival has been a challenge for nephrologists for decades. A common feature in late allograft failure is progressive interstitial fibrosis and tubular atrophy.[1] Increasing evidence points towards
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2839dc1c80db5a9c006d8c40f18f27fa
https://pure.au.dk/portal/da/publications/fc-118-the-effect-of-spironolactone-on-calcineurin-inhibitor-induced-nephrotoxicitythe-spiren-trial(8d093cea-c290-4b9b-b66d-0ac51c3396e7).html
https://pure.au.dk/portal/da/publications/fc-118-the-effect-of-spironolactone-on-calcineurin-inhibitor-induced-nephrotoxicitythe-spiren-trial(8d093cea-c290-4b9b-b66d-0ac51c3396e7).html
Autor:
Karl Emil Nelveg-Kristensen, Peter Bie, Laura Ferrero, Ditte Bjerre, Niels E Bruun, Martin Egfjord, Henrik B Rasmussen, Peter R Hansen, INDICES Consortium
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163341 (2016)
BACKGROUND:Variation in the carboxylesterase 1 gene (CES1) may contribute to the efficacy of ACEIs. Accordingly, we examined the impact of CES1 variants on plasma angiotensin II (ATII)/angiotensin I (ATI) ratio in patients with congestive heart failu
Externí odkaz:
https://doaj.org/article/c3ac87abed60406d8c7f03aa5de8bec7
Autor:
Niels H. Buus, Camilla Asferg, Jørgen Jeppesen, Bahareh Abdolalizadeh, Rasmus Dreier, Julie Lyng Forman, Lisbet Rosenkrantz Hölmich, Martin Egfjord, Majid Sheykhzade, Ulrik B. Andersen
Publikováno v:
Nephrology Dialysis Transplantation. 36:1282-1291
Background Increased potassium intake lowers blood pressure (BP) in hypertensive patients. The underlying mechanism is not fully understood but must be complex because increased potassium intake elevates circulating concentrations of the BP-raising h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5991b09d9f954794a8e9374c43339b99
https://doi.org/10.1093/ndt/gfaa114
https://doi.org/10.1093/ndt/gfaa114
Autor:
Nicholas Carlson, David Jayne, Per Ivarsen, Hans Dieperink, Christian Torp-Pedersen, Martin Egfjord, Jon Waarst Gregersen, Wladimir Szpirt, Elizabeth Krarup, Mark McClure, Karl Emil Nelveg-Kristensen
Publikováno v:
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, pp. 63–71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, gfaa303, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, gfaa303, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) carries a high risk of morbidity and mortality, with outcomes modified by treatment and an incidence that may be increasing. We examined temporal changes in incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fca7ea53f9911602ab4949d74546688
https://vbn.aau.dk/da/publications/0b46cd0d-9142-44dc-8834-af6016de4541
https://vbn.aau.dk/da/publications/0b46cd0d-9142-44dc-8834-af6016de4541
Autor:
Karl Emil Nelveg-Kristensen, Majbritt Busk Madsen, Christian Torp-Pedersen, Lars Køber, Martin Egfjord, Henrik Berg Rasmussen, Peter Riis Hansen
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144195 (2015)
Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two
Externí odkaz:
https://doaj.org/article/98d42e7367864356872c4568c07e928a